Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
WASHINGTON — Transplants of insulin-producing pancreas cells are a long hoped-for treatment for diabetes — and a new study shows they can protect the most seriously ill patients from a life-threatening complication of the disease, an important step toward US approval.
These transplants are used in some countries but in the US they’re available only through research studies. Armed with Monday’s findings, researchers hope to license them for use in a small number of people with type 1 diabetes who are most at risk for drops in blood sugar so severe they can lead to seizures, even death.
“Cell-based diabetes therapy is real and works and offers tremendous potential for the right patient,” said study lead author Dr. Bernhard Hering of the University of Minnesota, whose team plans to seek a Food and Drug Administration license for the therapy.
https://www.statnews.com/2016/04/18/diabetes-pancreas-cell-transplants/
These transplants are used in some countries but in the US they’re available only through research studies. Armed with Monday’s findings, researchers hope to license them for use in a small number of people with type 1 diabetes who are most at risk for drops in blood sugar so severe they can lead to seizures, even death.
“Cell-based diabetes therapy is real and works and offers tremendous potential for the right patient,” said study lead author Dr. Bernhard Hering of the University of Minnesota, whose team plans to seek a Food and Drug Administration license for the therapy.
https://www.statnews.com/2016/04/18/diabetes-pancreas-cell-transplants/
